Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
N6-Furfuryladenosine
Linifanib could cause a decrease in S and G2-M phases with a corresponding increase in the sub-G0-G1 apoptotic population in MV4-11 cells
InChi: InChI=1S/C31H35N3O8S/c1-31(2
The absence of effects on isolated atria preparations represents an interesting characteristic and suggests that SVT-40776 may lack unwanted cardiac effects
InChi: InChI=1S/C24H20N2O3/c1-17-7-5-9-19(13-17)16-29-21-12-6-8-18(14-21)15-22-23(27)25-26(24(22)28)20-10-3-2-4-11-20/h2-15H
NHS-MMAF - CAS# 1404073-19-3 mecrolimus N6-FurfuryladenosineNHS MMAF is a modified MMAF extracted from patent WO2012143499, intermediat 219. MMAF is a potent tubulin polymerization inhibitor and is used as a antitumor agent Product information CAS Number: 1404073 19 3 Molecular Weight: 943. 18 Formula: C49H78N6O12 Chemical Name: ((2R, 3R) 3 ((S) 1 ((3R, 4S, 5S) 4 ((S) 2 ((S) 2 ((6 ((2, 5 dioxopyrrolidin 1 yl)oxy) 6 oxohexyl)(methyl)amino) 3 methylbutanamido) N, 3 dimethylbutanamido) 3 methoxy 5
US$ 6905.50
US$ 1079.00
US$ 2843.50
US$ 185.00
US$ 1959.50
US$ 2319.00
US$ 1851.50
US$ 349.50
US$ 2117.00